Drug Profile
CR 15/01
Alternative Names: CR-15/01Latest Information Update: 14 Sep 2023
Price :
$50
*
At a glance
- Originator Conaris Research Institute
- Class Diagnostic agents
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Unspecified
Most Recent Events
- 13 Sep 2023 Discontinued - Preclinical for Unspecified (Diagnosis) in Germany (unspecified route) (Conaris Research Institiute pipeline, September 2023)
- 28 Jul 2020 No recent reports of development identified for preclinical development in Unspecified in Germany
- 27 Jun 2016 Preclinical trials in Unspecified (Diagnosis) in Germany (unspecified route)